This Week on Drug Topics: July 19 to July 23


Here’s a preview of the featured content to watch for this week on Drug Topics®.


Coronavirus Research News

The CDC estimates that 68.3% of US adults have received at least 1 COVID-19 vaccine as of this article’s press time. Keeping up with pandemic news is more important than ever, so check back to Drug Topics® to stay informed on the latest coronavirus-related news and research.

Read more coronavirus-related news.

The Latest from Total Pharmacy®: Medicare Part B Provider Status for Pharmacists: ‘A Unique Solution to a Specific Problem'

Ken Perez, MBA, vice president of health care policy and government affairs at Omnicell, discusses current legislation circulating the House and Senate to grant pharmacists provider status in underserved areas.

Read more on Total Pharmacy

Drug Topics® Journal, July 2021 Digital Edition

The July 2021 digital edition of Drug Topics Journal is now available on In this issue, you’ll find great insights into the latest pharmacy trends in independent community practice, diabetes, respiratory and autoimmune diseases, and more.

Read the latest issue of Drug Topics Journal.

Medical World News: Expert Interview with Jason Ausili

In the fourth and final segment, Jason Ausili, PharmD, considers the months ahead and why he believes the role of pharmacy will continue to increase through summer 2021.

Watch part 1, part 2, and part 3 of the video series

On Demand: What You Don't Know Can Cost You: Simple Ways to Make Data-Driven Decisions in Your Pharmacy

In this podcast episode with Jeff Harrell, PharmD, learn simple tools and tips to optimize profitability and streamline operations using objective data straight from your pharmacy.

Listen to more podcast episodes.

In Case You Missed It: FDA OKs Finerenone for Chronic Kidney Disease Associated With Type 2 Diabetes

A new medication called finerenone (Kerendia; Bayer) has been approved for the treatment of kidney disease and type 2 diabetes.

Read more

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.